Bausch Health Companies Inc share price logo

Bausch Health Companies Inc Share Price

NYSE: BHC

Mid Cap

$5.91

+0.08

(+1.46%)

as on

Bausch Health Companies Inc Stock Performance

as on April 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $5.83
    $5.95
    downward going graph

    1.35%

    Downside

    0.68%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $4.41
    $8.69
    downward going graph

    25.38%

    Downside

    46.95%

    Upside

    downward going graph

Bausch Health Companies Inc share price movements today

Previous Close
$5.82
Open
$5.90
Volume
2.0M
Day's Low - High
$5.83 - $5.95
52 Week Low - High
$4.41 - $8.69

Bausch Health Companies Inc Historical Returns

1 Month Return
+ 12.36 %
3 Month Return
-16.62 %
1 Year Return
+ 14.12 %
3 Year Return
-23.92 %
5 Year Return
-80.62 %

Bausch Health Companies Inc Stock Fundamentals & Key Indicators

Check Bausch Health Companies Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.2B

EPS (TTM)

4.3773

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

13.68%

PE Ratio (TTM)

13.86

Industry PE ratio

16.843333333333334

PEG Ratio

0.011

EBITDA

3.4B

Revenue (TTM)

10.3B

Profit Margin

1.53%

Return On Equity TTM

43.64%

Bausch Health Companies Inc Stock Valuation

Track how Bausch Health Companies Inc P/E has moved over time to understand its valuation trends.

Bausch Health Companies Inc in the last 5 years

  • Overview

  • Trends

Lowest (1.35x)

June 30, 2025

Today (13.86x)

April 17, 2026

Industry (16.84x)

April 17, 2026

Highest (6.50x)

June 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 13.86x

Bausch Health Companies Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bausch Health Companies Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
HOLD$2.2B-80.62%13.861.53%
BUY$25.4BNA20.8541.94%
HOLD$16.1B4.55%NA-24.58%
BUY$42.7BNA19.1815.11%
BUY$50.3B-28.99%20.0428.24%

Stock Returns calculator for Bausch Health Companies Inc Stock including INR - Dollar returns

The Bausch Health Companies Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bausch Health Companies Inc investment value today

Current value as on today

₹1,25,895

Returns

₹25,895

(+25.9%)

Returns from Bausch Health Companies Inc Stock

₹15,882 (+15.88%)

Dollar Impact

₹10,013 (+10.01%)

Analyst Recommendation on Bausch Health Companies Inc Stock

Based on 10 analysts

HOLD

0.00%

Buy

60.00%

Hold

40.00%

Sell

Based on 10 analysts, 60% of analysts recommend a 'HOLD' rating for Bausch Health Companies Inc. Average target price of $7.71

Bausch Health Companies Inc Share Price Target

Get share price movements and forecasts by analysts on Bausch Health Companies Inc.

What analysts predicted

23.35%UPSIDE

Target Price

$7.71

Current Price

$5.91

Analyzed by

10 Analysts

Target

$7.71

Bausch Health Companies Inc target price $7.71, a slight upside of 23.35% compared to current price of $5.91. According to 10 analysts rating.

Bausch Health Companies Inc Stock’s Investor Sentiment and Interest

Search interest for Bausch Health Companies Inc Stock has increased by 29% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:29% versus previous 30 day period

Bausch Health Companies Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
2,238
2,408
2,153
2,403
2,510
2,559
2,259
2,530
2,681
2,838
Gross Profit
1,615
1,703
1,513
1,684
1,814
1,832
1,558
1,766
1,931
1,789
Operating Income
14
362
281
389
318
558
276
444
619
730
EBITDA
795
836
619
744
866
901
602
764
936
659
Interest Expense
339
363
355
350
346
337
330
465
412
308
Depreciation
253
329
320
318
322
307
305
307
306
290
Income Before Tax
-326
-7
-69
47
-21
209
-47
140
218
56
Income Tax Expense
56
40
7
48
71
111
39
12
37
161
Net Income
-378
-39
-63
10
-85
93
-58
148
179
-113
Net Profit Margin
-16.89%
-1.62%
-2.96%
0.42%
-3.39%
3.63%
-2.57%
5.85%
6.68%
-4.01%

Bausch Health Companies Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
9,674
8,724
8,380
8,601
8,027
8,434
8,124
8,757
9,625
10,308
Gross Profit
7,101
6,176
6,029
6,251
5,778
6,040
5,760
6,198
6,843
7,044
Operating Income
-566
102
-2,384
-203
676
450
454
963
1,546
2,069
EBITDA
4,071
3,413
3,319
3,417
3,138
3,260
2,878
2,885
3,134
3,095
Interest Expense
1,836
1,840
1,685
1,612
1,534
1,426
1,464
1,328
1,388
1,515
Depreciation
-
2,858
2,819
2,075
1,825
1,375
1,215
1,264
1,267
1,208
Income Before Tax
-2,435
-1,741
-4,154
-1,837
-934
-1,024
-129
-390
167
367
Income Tax Expense
-27
-4,145
-10
-54
-375
-87
83
221
239
249
Net Income
-2,409
2,404
-4,148
-1,783
-559
-948
-225
-592
-46
155
Net Profit Margin
-24.90%
27.56%
-49.50%
-20.73%
-6.96%
-11.24%
-2.77%
-6.76%
-0.48%
1.51%

Bausch Health Companies Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-47
-77
9
-85
98
-86
128
181
-113
Operating Cash Flow
390
211
378
403
601
211
289
405
495
Investing Cash Flow
-148
-73
-78
-102
-200
-130
-100
-83
-286
Financing Cash Flow
-79
-340
-423
-186
85
-146
358
-719
-231
Change in Cash
182
-207
-131
125
451
-44
586
-403
-16

Bausch Health Companies Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
2,404
-4,144
-1,783
-559
-937
-212
-611
-72
120
Operating Cash Flow
2,290
1,501
1,501
1,111
1,426
-728
1,032
1,597
1,400
Investing Cash Flow
2,887
-196
-419
-261
409
-303
-2,145
-454
-595
Financing Cash Flow
-4,963
-1,353
1,443
-2,294
-1,513
-474
1,475
-868
-742
Change in Cash
255
-74
2,521
-1,428
303
-1,528
371
239
124

Global Institutional Holdings in Bausch Health Companies Inc

Funds
Holdings
Kohlberg Kravis Roberts & Co LP
1.4%
Royal Bank of Canada
2.81%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
2.26%
UBS Group AG
1.38%
BNP Paribas Arbitrage, SA
0.81%

Insights on Bausch Health Companies Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, BHC stock has moved up by 12.4%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 2.25B → 2.83B (in $), with an average increase of 7.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 152.0% return, outperforming this stock by 175.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation has given 103.9% return, outperforming this stock by 89.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 179.0M → -113.72M (in $), with an average decrease of 163.5% per quarter

About Bausch Health Companies Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; dermatology products; generic pharmaceutical products; and dentistry products. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
OrganisationBausch Health Companies Inc
Headquarters2150 St. ElzEar Boulevard West, Laval, QC, Canada, H7L 4A8
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Thomas J. Appio
E-voting on sharesClick here to vote

Key Management of Bausch Health Companies Inc

Name

Title

Mr. Thomas J. Appio

CEO & Director

Ms. Seana Carson

Executive VP & General Counsel

Mr. Cees Heiman

Senior Vice President of Europe & Canada

Ms. Jiny Kim M.B.A.

Senior Vice President of Solta Medical

Mr. Jean-Jacques Charhon

Executive VP & CFO

Ms. Aimee J. Lenar

Executive Vice President of US Pharma

Mr. Mirza Dautbegovic

Executive VP & COO

Mr. Steven H. Lee

Senior VP, Controller & Chief Accounting Officer

Mr. Garen Sarafian

VP & Head of Investor Relations

Ms. Kathleen Fitzpatrick

Executive VP and Chief HR & Communications Officer

FAQs

What is Bausch Health Companies Inc share price today?

Bausch Health Companies Inc share price today is $5.91 as on at the close of the market. Bausch Health Companies Inc share today touched a day high of $5.95 and a low of $5.83.

What is the 52 week high and 52 week low for Bausch Health Companies Inc share?

Bausch Health Companies Inc share touched a 52 week high of $8.69 on and a 52 week low of $4.41 on . Bausch Health Companies Inc stock price today i.e. is closed at $5.91,which is 31.95% down from its 52 week high and 34.01% up from its 52 week low.

What is Bausch Health Companies Inc's market capitalisation today?

Bausch Health Companies Inc market capitalisation is $0.00T as on .

How to invest in Bausch Health Companies Inc Stock (BHC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bausch Health Companies Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bausch Health Companies Inc Shares that will get you 0.2538 shares as per Bausch Health Companies Inc share price of $5.91 per share as on April 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Bausch Health Companies Inc Stock (BHC) from India?

Indian investors can start investing in Bausch Health Companies Inc (BHC) shares with as little as ₹92.768 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in Bausch Health Companies Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Bausch Health Companies Inc share’s latest price of $5.91 as on April 18, 2026 at 1:29 am IST, you will get 1.6920 shares of Bausch Health Companies Inc. Learn more about fractional shares .

What are the returns that Bausch Health Companies Inc has given to Indian investors in the last 5 years?

Bausch Health Companies Inc stock has given -80.62% share price returns and 24.45% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?